Last week, President Donald Trump announced a deal with pharmaceutical company Merck KGaA and its U.S. subsidiary, EMD Serono, to sharply reduce the cost of some fertility drugs used for in-vitro fertilization, in exchange for a three-year reprieve on some of the tariffs levied on pharmaceutical imports (The Cancer Letter, Oct. 24, 2025). To access […]
Trending
- Hypotaurine Market to Reach US$ 337 Million by 2031, Driven by IVF
- Is there a link between tobacco and men’s reproductive health? | Lifestyle Gallery News
- IVF Academy USA Appoints Chris Flynn, RN as Director of Nursing Programs
- McGill discovery could improve IVF success rates
- Do Cats Cause Infertility? Read the Full Explanation from IPB University Clinical Pathology Experts
- Cedars-Sinai Expert Debunks Fertility Cliff
- Nickelodeon star, 33, who hated her mom so much she was ‘glad’ when she died, REFUSES to have kids… despite freezing her eggs
- Novel cell division mechanism discovered in early embryonic development
Senators, nonprofits respond to Trump’s avowed support for IVF
